Not Yet Recruiting
A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Primary Aldosteronism
NCT07646535
- Conditions
- Adrenal Gland Diseases, Adrenocortical Hyperfunction, Endocrine System Diseases, +2 more
- Locations
-
- Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China